Support teaching, research, and patient care.
Dr. Bing Melody Zhang is board-certified by American Board of Pathology in Clinical Pathology and Molecular Genetic Pathology. She is also a certified and fully credentialed HLA laboratory director by American Society for Histocompatibility & Immunogenetics (ASHI) for the following areas--Solid Organ Transplantation: Deceased Donor; Solid Organ Transplantation: Live Donor; HSC/BM Transplantation: Related Donor; HSC/BM Transplantation: Unrelated Donor; Histocompatibility Testing for Other Clinical Purposes; Transfusion Support. Dr. Zhang completed Clinical Pathology residency, Molecular Genetic Pathology and Clinical Genomics fellowships, as well as Histocompatibility/Immunogenetics Director training at Stanford. She is currently the co-director of the HLA lab (Stanford Blood Center) and associate section director of the molecular pathology lab (Stanford Health Care). Her main research interests include genetic/genomic testing for malignant and non-malignant hematologic disorders, NGS-based TCR/Ig clonality/MRD testing, molecular testing for BMT/solid organ transplantation, and HLA-related disease association/drug hypersensitivity testing.
My main research interests lie in the following areas: 1) Using genetic/genomic approaches to study the genotype-phenotype correlation of inherited non-malignant hematologic disorders, especially platelet disorders. 2) Development and application of molecular assays for clinical testing to support hematopoietic stem cell transplantation and solid organ transplantation.3) NGS-based TCR/Ig clonality/MRD diagnostic testing.4) HLA-related disease association and pharmacogenetic testing.